Lumida
/PCVX
⌘K
Vaxcyte Inc

Vaxcyte Inc

PCVX
$59.47USD+0.97%+0.57 today

MARKET CAP

8.8B

P/E (TTM)

FWD P/E

DAY RANGE

$58 – $60

52W RANGE

$31
$65

AI Summary

Stalk
Sell NowMedium

PCVX is exhibiting a bearish pivot breakdown in a Stage 4 downtrend, with the recent failure to reclaim the 9 and 20 EMAs signaling a shift toward structural repair. Medium-term bias remains bearish, reinforced by price below the 50 SMA and the active Bearish Pivot Point pattern. Short-term rejection at the 9/20 EMA resistance zone confirms that timing favors selling into rallies. Selling now into the 59.99–60.10 zone aligns with the Momentum + EPS strategy’s preference for participating in momentum breakdowns.

  • Vax31 may boost serotype coverage 45%, capturing market share
  • $3.13B cash runway underwrites R&D and ops through 2025
  • R&D expenses forecasted at $480M in 2025, pressuring cash
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICTREND
Sales, Adj.
YoY %
P / Sales
EV / Sales
Gross Profit, Adj.
YoY %
Margin %
EV / Gross Profit
EBITDA, Adj.
YoY %
Margin %
EV / EBITDA
EBIT
YoY %
Margin %
EV / EBIT
Net Income
YoY %
Net Margin
EPS (GAAP)
YoY %